Rockwell Medical (RMTI) Amortization of Deferred Charges (2014 - 2026)
Rockwell Medical's (RMTI) quarterly Amortization of Deferred Charges came in at $90000.0 in Q2 2026, up 2.27% on a YoY basis from $88000.0 in Q2 2025, and up 2.27% quarter-over-quarter from $88000.0 in Q1 2026.
Powered by 
Analysis
Rockwell Medical (RMTI) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has reported Amortization of Deferred Charges for 11 consecutive years, with $90000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortization of Deferred Charges rose 2.27% year-over-year to $90000.0; the trailing twelve-month figure through Jun 2026 stood at $356000.0 (up 0.85% YoY), and the FY2025 full-year result was $354000.0, down 16.9% from the prior year.
- Amortization of Deferred Charges climbed to $90000.0 in Q2 2026 per RMTI's latest filing, from $88000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $831000.0 in Q4 2023 and bottomed at $30000.0 in Q2 2024.
- Historically, Amortization of Deferred Charges has averaged $135222.2 across 5 years, with a median of $91000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges surged 793.55% in 2023, then tumbled 89.29% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at $93000.0 in 2022, then soared by 793.55% to $831000.0 in 2023, then sank by 89.29% to $89000.0 in 2024, then changed by 0.0% to $89000.0 in 2025, then climbed by 1.12% to $90000.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $90000.0, $88000.0, and $89000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Dec 31, 2023 | 831,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 92,000.00 |
| Mar 31, 2023 | 92,000.00 |
| Dec 31, 2022 | 93,000.00 |
| Sep 30, 2022 | 92,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 93,000.00 |
| Sep 30, 2021 | 92,000.00 |